A novel tumor-related protein, C7orf24, identified by proteome differential display of bladder urothelial carcinoma

被引:54
作者
Kageyama, Susumu
Iwaki, Hideaki
Inoue, Hirokazu
Isono, Takahiro
Yuasa, Takeshi
Nogawa, Masaki
Maekawa, Taira
Ueda, Masamichi
Kajita, Yoichiro
Ogawa, Osamu
Toguchida, Junya
Yoshiki, Tatsuhiro [1 ]
机构
[1] Shiga Univ Med Sci, Dept Urol, Otsu, Shiga 5202192, Japan
[2] Shiga Univ Med Sci, Dept Microbiol, Otsu, Shiga 5202192, Japan
[3] Shiga Univ Med Sci, Cent Res Lab, Otsu, Shiga 5202192, Japan
[4] Kyoto Univ, Grad Sch Med, Dept Transfus Med & Cell Therapy, Kyoto, Japan
[5] Kyoto Univ, Inst Virus Res, Dept Biol Responses, Kyoto, Japan
[6] Kyoto Univ, Grad Sch Med, Dept Urol, Kyoto, Japan
[7] Kyoto Univ, Inst Frontier Med Sci, Kyoto, Japan
关键词
bladder neoplasms; hypothetical protein; siRNA;
D O I
10.1002/prca.200600468
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Proteome analysis of bladder cancer with narrow-range pH 2-DE has identified a novel protein on chromosome 7 encoded by ORF 24 (Oorf24) as one of the highly expressed proteins in cancer cells. C7orf24 is currently registered in the protein database as a hypothetical protein with unknown function. The homologs of C7orf24 in other animals have also been registered as putative protein genes. Western blot analysis using a mAb against C7orf24 confirmed its higher expression in bladder cancer compared with normal tissue. Several other cancer cell lines were also found to express C7orf24. However, the introduction of C7orf24 into Rat-1 or NIH3T3 cells did not cause malignant transformation. A stable transfectant of NIH3T3 cells with recombinant retrovirus vector was produced for a growth rate assay, and a higher growth rate was observed in C7orf24-expressing cells compared with the controls. Six kinds of small interfering RNAs (siRNAs) were then produced, and C7orf24-siRNA#5 showed a strong knockdown effect on protein expression and significant antiproliferative effects on cancer cell lines were demonstrated by the MTT assay. Therefore, C7orf24 may have an important role in cancer cell proliferation, and may be an appropriate therapeutic target molecule against cancer.
引用
收藏
页码:192 / 199
页数:8
相关论文
共 10 条
[1]   Refractory nature of normal human diploid fibroblasts with respect to oncogene-mediated transformation [J].
Akagi, T ;
Sasai, K ;
Hanafusa, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (23) :13567-13572
[2]   Proteomics: new perspectives, new biomedical opportunities [J].
Banks, RE ;
Dunn, MJ ;
Hochstrasser, DF ;
Sanchez, JC ;
Blackstock, W ;
Pappin, DJ ;
Selby, PJ .
LANCET, 2000, 356 (9243) :1749-1756
[3]  
Isono T, 2002, CLIN CHEM, V48, P2187
[4]   Identification by proteomic analysis of calreticulin as a marker for bladder cancer and evaluation of the diagnostic accuracy of its detection in urine [J].
Kageyama, S ;
Isono, T ;
Iwaki, H ;
Wakabayashi, Y ;
Okada, Y ;
Kotani, K ;
Yoshimura, K ;
Terai, A ;
Arai, Y ;
Yoshiki, T .
CLINICAL CHEMISTRY, 2004, 50 (05) :857-866
[5]   High expression of human uroplakin Ia in urinary bladder transitional cell carcinoma [J].
Kageyama, S ;
Yoshiki, T ;
Isono, T ;
Tanaka, T ;
Kim, CJ ;
Yuasa, T ;
Okada, Y .
JAPANESE JOURNAL OF CANCER RESEARCH, 2002, 93 (05) :523-531
[6]   Proteomics and disease: opportunities and challenges [J].
Kavallaris, M ;
Marshall, GM .
MEDICAL JOURNAL OF AUSTRALIA, 2005, 182 (11) :575-579
[7]   Intravesical administration of small interfering RNA targeting PLK-1 successfully prevents the growth of bladder cancer [J].
Nogawa, M ;
Yuasa, T ;
Kimura, S ;
Tanaka, M ;
Kuroda, J ;
Sato, K ;
Yokota, A ;
Segawa, H ;
Toda, Y ;
Kageyama, S ;
Yoshiki, T ;
Okada, Y ;
Maekawa, T .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (04) :978-985
[8]   Proteomic analysis for the early detection and rational treatment of cancer - realistic hope? [J].
Posadas, EM ;
Simpkins, F ;
Liotta, LA ;
MacDonald, C ;
Kohn, EC .
ANNALS OF ONCOLOGY, 2005, 16 (01) :16-22
[9]   Antitumor activity of small interfering RNA/cationic liposome complex in mouse models of cancer [J].
Yano, J ;
Hirabayashi, K ;
Nakagawa, S ;
Yamaguchi, T ;
Nogawa, M ;
Kashimori, I ;
Naito, H ;
Kitagawa, H ;
Ishiyama, K ;
Ohgi, T ;
Irimura, T .
CLINICAL CANCER RESEARCH, 2004, 10 (22) :7721-7726
[10]  
Yoshiki T, 1995, Int J Urol, V2, P261, DOI 10.1111/j.1442-2042.1995.tb00469.x